Happy 7-11 Day!
We hope everyone’s on their way to get their free slurpie today! For this week’s editor’s choice, we’re highlighting four articles. First, we discuss kratom, the controversial pain-relief alternative. Next, we have updates on a multiple myeloma treatment, CRISPR progress, and new insight into ankylosing spondylitis.
Sit back and enjoy the holiday and this week’s Editor’s Choice!
Some people swear by kratom, others are sketpical. We’re hoping this new research will shed some light on the supplement.
This treatment will need to go through more trials, but has just received good news from the FDA.
A researcher in Russia is taking strides to implement CRISPR in humans.
Just because it’s called “nonsense” RNA, doesn’t mean it’s not worth understanding!